By Ben Butkus
MONTREAL – Early-stage molecular diagnostics firm QuantumDx said today that it has exclusively licensed from Nanosys the rights to use nanowire field effect transistor biosensors in biomarker detection and sequencing applications.
...and receive Daily News bulletins.
Already have an account?Login Now.
The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.
Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.
Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.
In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.
This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.